Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
George Morstyn Insider Profile
4 Followers
George Morstyn, Director at Actinogen Medical Limited, holds 11.97M shares in Actinogen Medical Limited (Ticker: ATGGF). Most recently, George Morstyn Bought $748,425 shares of Actinogen Medical Limited on Jun 07, 2024 for an estimated value of 18.71K.
George Morstyn has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of George Morstyn's holdings
Insider Roles
Director
Roles that George Morstyn holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by George Morstyn
George Morstyn's Trading History
List of latest transactions for each holding click on a transaction to see George Morstyn's performance on stock
You May Also Like
George Morstyn insider profile FAQ
What is the percentage of profitable transactions made by George Morstyn?
The percentage of profitable transactions made by George Morstyn is ―.
What is the average return per transaction made by George Morstyn?
The average return per transaction made by George Morstyn is ―.
What stocks does George Morstyn hold?
George Morstyn holds: ATGGF stocks.
What was George Morstyn’s latest transaction?
George Morstyn latest transaction was an Informative Buy of $18.71K.
What was George Morstyn's most profitable transaction?
George Morstyn’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is George Morstyn's role in Actinogen Medical Limited?
George Morstyn's role in Actinogen Medical Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.